Carlsmed names Richard Heppenstall CFO, replacing Leo Greenstein
CARL•Carlsmed named Richard Heppenstall chief financial officer, effective immediately, replacing Leo Greenstein, who is leaving to pursue other interests. The company reaffirmed full-year 2026 revenue guidance of $74 million to $78 million.




